GORDON CARL L
SEC Form 4 insider trading activity
GORDON CARL L has filed 3 SEC Form 4 filings (7 transaction rows) across 3 companies, including BLSM, SCTX, KROS, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Aug 12, 2026.
On the most recent filing, GORDON CARL L is listed as Director at BlossomHill Therapeutics, Inc. Inside the rolling window, GORDON CARL L reported 2 open-market purchases totaling $25.0M in BLSM and SCTX and no open-market sales. The largest disclosed transaction in the window is a purchase of 1,000,000 SCTX shares on Jul 27, 2026, worth $15.0M.
Companies traded
Other insiders at BLSM
Insider Buying
$25.0M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
3
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has GORDON CARL L made?
GORDON CARL L has filed 3 SEC Form 4 filings (7 transaction rows) across 3 companies, including BLSM, SCTX, KROS since 2025.
Which companies does GORDON CARL L trade?
GORDON CARL L has filed SEC Form 4 disclosures for 3 companies, including BLSM, SCTX, KROS.
When was GORDON CARL L's most recent SEC Form 4 filing?
GORDON CARL L's most recent SEC Form 4 filing on Tracefour is dated Aug 12, 2026.
What is GORDON CARL L's total buy and sell value in the current window?
Inside the rolling retention window, GORDON CARL L bought $25.0M and sold $0 based on SEC Form 4 filings.
What was GORDON CARL L's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 1,000,000 SCTX shares on 2026-07-27, worth $15.0M, per SEC Form 4 filings.